Acute pulmonary embolism (PE) can diminish patient quality of life (QoL). The objective was
to test whether treatment with tenecteplase has an independent effect on a measurement …

As a common clinical emergency, pulmonary embolism (PE) is the third most fatal
cardiovascular disease worldwide. Although current sophisticated medical technology has …

Most patients with acute pulmonary embolism (PE) are still treated as inpatients. This is a
retrospective cohort study of patients with acute PE, diagnosed using V/P SPECT between …

Background: Management of patients with acute pulmonary embolism has evolved from
obligatory hospitalization to home treatment of carefully selected low-risk patients. The …

In the 1970s, both the Urokinase Pulmonary Embolism and Urokinase-Streptokinase
Pulmonary Embolism trials began the quest to develop thrombolytic therapy for the treatment …

Background Many patients with pulmonary embolism (PE) report dyspnea on exertion
following long-term treatment. Increased physiological dead space proportion (VD/VT) and …

Introduction Although quality of life (QoL) is recognized as an important indicator of the
course of a disease, it has rarely been addressed in studies evaluating the outcome of care …

Acute pulmonary embolism (PE) is not only a serious and potentially life-threatening disease
in the acute phase, in recent years it has become evident that it may also have a major …

Background Pulmonary embolism (PE) is the third most common cause of cardiovascular
death. However, comprehensive knowledge on the lived experience of patients with PE is …

Rationale: Studies of adults presenting to the emergency department (ED) with acute
pulmonary embolism (PE) suggest that those who are low risk on the PE Severity Index …